NKGen Biotech (NKGN) Stock Chart & Stock Price History $0.14 0.00 (0.00%) As of 09:30 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NKGen Biotech Stock Price Performance The NKGen Biotech (NKGN) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 86.92%, with a year-to-date return of -78.63%. In the past month, the stock has decreased 53.33%, reflecting recent market activity. As of the latest close, NKGen Biotech traded at $0.14 with a market cap of $6.29 million and volume of 35,417 shares. Receive NKGN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NKGen Biotech and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance0.00%1 Month Performance-53.33%3 Month Performance+10.15%Year-To-Date Performance-78.63%1 Year Performance-86.92% NKGN Stock Chart for Monday, August, 4, 2025 NKGN Chart by TradingView NKGen Biotech Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025$0.14$0.14$0.15$0.1435,417 shs$6.29 million07/31/2025$0.14$0.14$0.14$0.145,164 shs$6.29 million07/30/2025$0.14$0.14$0.14$0.1437,571 shs$6.29 million07/29/2025$0.19$0.14-26.32%$0.18$0.147,045 shs$6.29 million07/28/2025$0.19$0.19$0.19$0.19832 shs$8.54 million07/25/2025$0.19$0.19$0.22$0.1982,166 shs$8.54 million07/24/2025$0.22$0.19-13.64%$0.22$0.1982,166 shs$8.54 million07/23/2025$0.21$0.22+4.76%$0.22$0.2030,935 shs$9.89 million07/22/2025$0.24$0.21-12.50%$0.22$0.21558 shs$9.44 million07/21/2025$0.24$0.24$0.24$0.20117,770 shs$10.79 million Get the Latest News and Ratings for NKGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NKGen Biotech and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025$0.25$0.24-4.00%$0.27$0.2026,099 shs$10.79 million07/17/2025$0.26$0.25-3.85%$0.31$0.24899,239 shs$11.24 million07/16/2025$0.28$0.26-7.14%$0.28$0.2664,430 shs$11.69 million07/15/2025$0.30$0.28-7.01%$0.31$0.26170,192 shs$12.59 million07/14/2025$0.30$0.30+0.33%$0.32$0.30141,361 shs$13.53 million07/11/2025$0.30$0.30+0.03%$0.31$0.3092,670 shs$13.49 million07/10/2025$0.30$0.30-0.17%$0.33$0.3064,405 shs$13.48 million07/09/2025$0.31$0.30-3.06%$0.32$0.3036,458 shs$13.51 million07/08/2025$0.30$0.31+3.33%$0.32$0.27224,608 shs$13.93 million07/07/2025$0.30$0.30$0.31$0.2760,996 shs$13.48 million07/04/2025$0.30$0.30$0.31$0.2746,117 shs$13.48 million07/03/2025$0.30$0.30$0.31$0.2746,117 shs$13.48 million Related Companies Longeveron Stock Price Chart Cyclacel Pharmaceuticals Stock Price Chart Aspire Biopharma Stock Price Chart Aytu BioPharma Stock Price Chart Reviva Pharmaceuticals Stock Price Chart Dare Bioscience Stock Price Chart Calidi Biotherapeutics Stock Price Chart Cadrenal Therapeutics Stock Price Chart Lisata Therapeutics Stock Price Chart Natural Alternatives International Stock Price Chart Receive NKGN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NKGen Biotech and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:NKGN) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NKGen Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NKGen Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.